HL

Herbalife Ltd.

HLFConsumer DefensiveNASDAQ

Packaged Foods · Last scanned Jul 17, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$5.04B
+0.9% YoY
Net Income
$228.3M
-10.2% YoY
EBITDA
$610.7M
+20.0% YoY
Free Cash Flow
$349.0M

Scan Results

Daily timeframe
1 recent day hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 2 RSI OverboughtRSI 70.1, above 70, stock may be overbought
Jul 1CONFIRMED RSI OverboughtRSI 73.1, above 70, stock may be overbought
Below MA2000.6% below MA200
About Herbalife Ltd.

Herbalife Ltd., together with its subsidiaries, provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company carries a $1.28B market cap, placing it firmly in the small-cap category. It offers weight management products, including meal replacement, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism boosting teas; targeted nutrition products comprising functional beverages and dietary and nutritional supplements containing herbs, vitamins, minerals and other natural ingredients; energy, sports, and fitness products; and facial skin care, body care, and hair care products.

Key stats
Market Cap$1.28B
P/E (TTM)5.47
Fwd P/E3.92
EPS$2.26
Beta0.87
52W Change+35.0%
Analysis

The company holds $451.2M in cash, though total debt stands at $2.18B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $349.0M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on assets of 11.5% further supports the picture of efficient asset utilization. Revenue has been relatively flat, moving from $5.20B (2022) to $5.04B (2025).

As with any equity investment, HLF carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Herbalife Ltd.'s trajectory.

Links
More Consumer Defensive stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms